PL3818059T3 - Produkty pośrednie w syntezie c-podstawionych cefalosporyn - Google Patents
Produkty pośrednie w syntezie c-podstawionych cefalosporynInfo
- Publication number
- PL3818059T3 PL3818059T3 PL19736478.9T PL19736478T PL3818059T3 PL 3818059 T3 PL3818059 T3 PL 3818059T3 PL 19736478 T PL19736478 T PL 19736478T PL 3818059 T3 PL3818059 T3 PL 3818059T3
- Authority
- PL
- Poland
- Prior art keywords
- intermediates
- synthesis
- substituted cephalosporins
- cephalosporins
- substituted
- Prior art date
Links
- 229930186147 Cephalosporin Natural products 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 229940124587 cephalosporin Drugs 0.000 title 1
- 150000001780 cephalosporins Chemical class 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/08—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/08—Preparation by forming the ring or condensed ring systems
- C07D501/10—Preparation by forming the ring or condensed ring systems from compounds containing the penicillin ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
- C07C45/676—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1810849.8A GB2575261B (en) | 2018-07-02 | 2018-07-02 | Intermediates in the synthesis of C3-substituted cephalosporins |
| PCT/GB2019/051871 WO2020008183A1 (en) | 2018-07-02 | 2019-07-02 | Intermediates in the synthesis of c3-substituted cephalosporins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3818059T3 true PL3818059T3 (pl) | 2024-09-30 |
Family
ID=63143782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19736478.9T PL3818059T3 (pl) | 2018-07-02 | 2019-07-02 | Produkty pośrednie w syntezie c-podstawionych cefalosporyn |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11840544B2 (pl) |
| EP (1) | EP3818059B1 (pl) |
| AU (1) | AU2019298749B2 (pl) |
| CA (1) | CA3104110A1 (pl) |
| DK (1) | DK3818059T3 (pl) |
| ES (1) | ES2985585T3 (pl) |
| FI (1) | FI3818059T3 (pl) |
| GB (1) | GB2575261B (pl) |
| HR (1) | HRP20241106T1 (pl) |
| PL (1) | PL3818059T3 (pl) |
| PT (1) | PT3818059T (pl) |
| SI (1) | SI3818059T1 (pl) |
| WO (1) | WO2020008183A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111892612A (zh) * | 2020-07-31 | 2020-11-06 | 重庆医药高等专科学校 | 一种以青霉素钾盐为原料制备头孢维星的中间体异构化物及其制备方法 |
| CN111763221A (zh) * | 2020-07-31 | 2020-10-13 | 重庆医药高等专科学校 | 一种头孢维星中间体及其制备方法 |
| CN112409382A (zh) * | 2020-11-26 | 2021-02-26 | 浙江普洛得邦制药有限公司 | 一种盐酸头孢他美酯的合成方法 |
| CN115873021A (zh) * | 2022-12-19 | 2023-03-31 | 华北制药集团动物保健品有限责任公司 | 一种头孢维星钠的制备方法 |
| CN117186116B (zh) * | 2023-09-07 | 2024-06-07 | 浙江荣耀生物科技股份有限公司 | 一种头孢维星中间体的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518528A (en) * | 1983-05-19 | 1985-05-21 | Rasnick David W | α Amino fluoro ketones |
| MY106399A (en) | 1990-07-24 | 1995-05-30 | Pfizer | Cephalosporins and homologeus, preparation and pharmaceutical composition |
| GB2300856A (en) | 1995-05-16 | 1996-11-20 | Pfizer Ltd | Beta-lactam preparation |
| GB0019124D0 (en) | 2000-08-03 | 2000-09-27 | Pfizer | Novel process |
| AU2002223943B2 (en) | 2000-12-04 | 2006-10-05 | Pfizer Products Inc. | Coupling process and intermediates useful for preparing cephalosphorins |
| DK1339723T3 (da) | 2000-12-04 | 2006-06-12 | Pfizer Prod Inc | Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner |
| US7378408B2 (en) | 2001-11-30 | 2008-05-27 | Pfizer Inc. | Methods of treatment and formulations of cephalosporin |
| CN1930173A (zh) | 2004-03-09 | 2007-03-14 | 辉瑞产品公司 | 使用α－碘代－1－氮杂环丁烷乙酸酯和三烷基亚磷酸盐制备头孢菌素中间体的方法 |
| US7560575B2 (en) * | 2005-12-28 | 2009-07-14 | Acino Pharma Ag | Process for preparation of racemic Nebivolol |
| WO2010117796A2 (en) * | 2009-03-30 | 2010-10-14 | Codexis, Inc. | Processes for the preparation of alpha-chloroketones from carboxylic acids |
-
2018
- 2018-07-02 GB GB1810849.8A patent/GB2575261B/en active Active
-
2019
- 2019-07-02 FI FIEP19736478.9T patent/FI3818059T3/fi active
- 2019-07-02 WO PCT/GB2019/051871 patent/WO2020008183A1/en not_active Ceased
- 2019-07-02 DK DK19736478.9T patent/DK3818059T3/da active
- 2019-07-02 PT PT197364789T patent/PT3818059T/pt unknown
- 2019-07-02 ES ES19736478T patent/ES2985585T3/es active Active
- 2019-07-02 AU AU2019298749A patent/AU2019298749B2/en active Active
- 2019-07-02 US US17/255,371 patent/US11840544B2/en active Active
- 2019-07-02 EP EP19736478.9A patent/EP3818059B1/en active Active
- 2019-07-02 CA CA3104110A patent/CA3104110A1/en active Pending
- 2019-07-02 PL PL19736478.9T patent/PL3818059T3/pl unknown
- 2019-07-02 SI SI201930797T patent/SI3818059T1/sl unknown
- 2019-07-02 HR HRP20241106TT patent/HRP20241106T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3104110A1 (en) | 2020-01-09 |
| GB2575261B (en) | 2022-03-09 |
| AU2019298749B2 (en) | 2024-04-11 |
| GB2575261A (en) | 2020-01-08 |
| EP3818059A1 (en) | 2021-05-12 |
| ES2985585T3 (es) | 2024-11-06 |
| PT3818059T (pt) | 2024-08-16 |
| FI3818059T3 (fi) | 2024-08-14 |
| DK3818059T3 (da) | 2024-08-19 |
| SI3818059T1 (sl) | 2024-10-30 |
| GB201810849D0 (en) | 2018-08-15 |
| US11840544B2 (en) | 2023-12-12 |
| US20210261571A1 (en) | 2021-08-26 |
| WO2020008183A1 (en) | 2020-01-09 |
| EP3818059B1 (en) | 2024-05-22 |
| HRP20241106T1 (hr) | 2024-11-08 |
| AU2019298749A1 (en) | 2021-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3818059T (pt) | Intermediários na síntese de cefalosporinas substituídas em c3 | |
| SI3645518T1 (sl) | Sinteza omekamtiv mekarbila | |
| GB201609089D0 (en) | Improving the sound quality of virtualisation | |
| GB201805453D0 (en) | Novel use | |
| SG11202103001PA (en) | Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application | |
| SG11202010677XA (en) | Methods for the production of methacrylates | |
| ZA202101214B (en) | Process and intermediates for the preparation of bilastine | |
| PL3845521T3 (pl) | Sposoby syntezy upadacytynibu i jego produktów pośrednich | |
| IL291221A (en) | Methods for the synthesis of wolbenzine | |
| ZA202105399B (en) | Use of spiropidion | |
| IL279365B1 (en) | Synthesis of coelantrazine | |
| PL3737685T3 (pl) | Sposób wytwarzania kryzaborolu i jego związków pośrednich | |
| GB201812078D0 (en) | Novel compounds and their uses | |
| IL276107A (en) | Crystalline forms of psoorstam | |
| GB201915447D0 (en) | Polymorphs of avapritinib and methods of preparing the polymorphs | |
| PL3966214T3 (pl) | Synteza koelenterazyny | |
| LT3405467T (lt) | Nebivololo tarpinių junginių sintezės būdas | |
| PT3759082T (pt) | Processo para a síntese de 6-clorometiluracilo | |
| PT3713939T (pt) | Processo melhorado para a síntese de fármaco ligante vcseco- duba | |
| GB201804905D0 (en) | Cataltic synthesis of biarylic compounds | |
| PT3901141T (pt) | Nova forma de isoquinolinossulfonamida | |
| GB201917499D0 (en) | Methods of synthesis | |
| GB201918058D0 (en) | The generic approach of the blockchain interoperability | |
| GB201807468D0 (en) | Methods of synthesis | |
| GB201820685D0 (en) | Synthesis of 8-chloroadenosine derivatives |